c-Jun phosphorylated by JNK is required for protecting Gli2 from proteasomal-ubiquitin degradation by PGE2-JNK signaling axis

被引:2
|
作者
Yang, Jun [1 ]
Wang, Juan [1 ]
Zhang, Yu [1 ]
Huang, Wenjing [1 ]
Zhang, Shaoqing [1 ]
Yin, Peihao [2 ]
Tan, Wenfu [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Gen Surg, Shanghai 200062, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
c-Jun; Hedgehog; Gli; PGE2-JNK; Proteasomal-ubiquitin degradation; Colorectal cancer; HEDGEHOG PATHWAY; ADENOMA GROWTH; TUMOR-GROWTH; ACTIVATION; CANCER; CELLS; TRANSDUCTION; PROTEINS;
D O I
10.1016/j.bbamcr.2022.119418
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hedgehog (Hh) signaling pathway includes canonical and non-canonical activation manners. In colorectal cancer, we have previously shown that PGE2-JNK could initiate non-canonical activation of the Hh signaling pathway. In this study, we showed that c-Jun, a classic substrate of JNK, increased Gli2 protein stability after phosphorylated by PGE2. Suppressing the function of c-Jun or JNK indicated that c-Jun prevents Gli2 from protease degradation caused by PGE2-JNK. Moreoer, we revealed that less ubiquitination of Gli2 was detected in colorectal cancer cells treated with PGE2 while suppression of c-Jun restored the ubiquitination of Gli2. In addition, we observed that suppression of c-Jun significantly decreased Gli2 expression no matter when Gli2 remained in phosphorylation or non-phosphorylation state. These phenomena were recapitulated, when the endpoint of Gli2 expression was replaced by Gli2 ubiquitination. Furthermore, we demonstrated that restricting c-Jun function ablated the PGE2-provoked Hh activity and proliferation of colorectal cancer cells. These results elucidated that the evasion of Gli2 with phosphorylation from proteasomal-ubiquitin degradation needed the cooperation of phosphorylated c-Jun by kinase JNK, which contributed to promoting Hh activation and the proliferation of colorectal cancer cells. This study provides a theoretical foundation to target PGE2 downstream for the prevention and treatment of colorectal cancer.
引用
收藏
页数:8
相关论文
共 47 条
  • [21] C-Jun N-Terminal Kinase-2 (JNK2) plays a crucial role in alcohol and corticosterone-induced tissue enjury at the gut-liver axis
    Basa, Lohitha
    Shukla, Pradeep
    Meena, Avtar
    Shashikanth, Nitesh
    Shekhar, Chandra
    Raju, Preeti
    Swarna, Samhitha
    Pierre, Joseph
    Rao, RadhaKrishna
    ALCOHOL, 2023, 113 : 57 - 57
  • [22] β2 Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models
    Wang, Dayong
    Fu, Qin
    Zhou, Yuan
    Xu, Bing
    Shi, Qian
    Igwe, Benedict
    Matt, Lucas
    Hell, Johannes W.
    Wisely, Elena V.
    Oddo, Salvatore
    Xiang, Yang K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (15) : 10298 - 10307
  • [23] Multidrug resistance effected by bcl-2 in AML is transcriptionally regulated downstream from Flt3 through a JNK pathway to c-jun/ATF2: A novel JNK inhibitor causes apoptosis in patient blasts
    Wilson-Weekes, A.
    Cripe, L. D.
    Hartmans, A. D.
    Friedman, G.
    Worland, P.
    Bennett, B.
    Boxer, L. M.
    Klemsz, M. J.
    Nakshatri, H.
    Boswell, H. S.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 37 - 37
  • [24] The MAP2K4/JNK/c-Jun Signaling Pathway Plays A Key Role In Dexmedetomidine Protection Against Acetaminophen-Induced Liver Toxicity
    Chou, An-Hsun
    Liao, Chia-Chih
    Lee, Hung-Chen
    Liou, Jiin-Tarng
    Liu, Fu-Chao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 3887 - 3898
  • [25] The rapid induction of c-Jun n-terminal kinase (JNK) signaling associated with liver regeneration is mediated via the activation of P2 purinergic receptors.
    Thevananther, S
    Sun, HD
    Awad, SS
    Wyllie, S
    Karpen, SJ
    HEPATOLOGY, 2003, 38 (04) : 215A - 215A
  • [26] Endothelin-1 activates C-jun NH2-terminal kinase (JNK) in mesangial cells: A mechanism different from ERK activation.
    Araki, S
    Haneda, M
    Togawa, M
    Kikkawa, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2109 - A2109
  • [27] Tumor-secreted LCN2 impairs gastric cancer progression via autocrine inhibition of the 24p3R/JNK/c-Jun/SPARC axis
    Huang, Zhixin
    Li, Ying
    Qian, Yan
    Zhai, Ertao
    Zhao, Zeyu
    Zhang, Tianhao
    Liu, Yinan
    Ye, Linying
    Wei, Ran
    Zhao, Risheng
    Li, Zikang
    Liang, Zhi
    Cai, Shirong
    Chen, Jianhui
    CELL DEATH & DISEASE, 2024, 15 (10):
  • [28] Duox1-Derived H2O2 Modulates Cxcl8 Expression and Neutrophil Recruitment via JNK/c-JUN/AP-1 Signaling and Chromatin Modifications
    de Oliveira, Sofia
    Boudinot, Pierre
    Calado, Angelo
    Mulero, Victoriano
    JOURNAL OF IMMUNOLOGY, 2015, 194 (04): : 1523 - 1533
  • [29] Tyrosine-phosphorylated Caveolin-1 (Tyr-14) Increases Sensitivity to Paclitaxel by Inhibiting BCL2 and BCLxL Proteins via c-Jun N-terminal Kinase (JNK)
    Shajahan, Ayesha N.
    Dobbin, Zachary C.
    Hickman, F. Edward
    Dakshanamurthy, Sivanesan
    Clarke, Robert
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (21) : 17682 - 17692
  • [30] The c-Jun N-terminal Kinase (JNK)-binding Protein (JNKBP1) Acts as a Negative Regulator of NOD2 Protein Signaling by Inhibiting Its Oligomerization Process
    Lecat, Aurore
    Di Valentin, Emmanuel
    Somja, Joan
    Jourdan, Samuel
    Fillet, Marianne
    Kufer, Thomas A.
    Habraken, Yvette
    Sadzot, Catherine
    Louis, Edouard
    Delvenne, Philippe
    Piette, Jacques
    Legrand-Poels, Sylvie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (35) : 29213 - 29226